EIKN Eikon Therapeutics, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026EIKN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
EIKN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | EIKN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.9 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | EIKN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 9.9 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-1.63 | $-1.62 | -0.82% |
| March 31, 2026 | $-2.46 | $-1.78 | -38.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $105M | |
| Short-term Investments | $231M | |
| Prepaid Expense | $13M | |
| Current Assets | $349M | |
| PP&E (Net) | $143M | |
| PP&E (Gross) | $186M | |
| Accum. Depreciation | $43M | |
| Other Non-current Assets | $4M | |
| Total Assets | $595M | |
| Accounts Payable | $681.0K | |
| Current Liabilities | $55M | |
| Capital Leases | $247M | |
| Other Non-current Liabilities | $10M | |
| Total Liabilities | $312M | |
| Common Stock | $0 | |
| Retained Earnings | $-921M | |
| Stockholders' Equity | $-879M | |
| Liabilities + Equity | $595M | |
| Shares Outstanding | 3,068,490 |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| R&D Expense | $75M | $70M | $69M | $57M | |
| SG&A Expense | $18M | $17M | $40M | $15M | |
| Operating Expenses | $93M | $87M | $110M | $71M | |
| Operating Income | $-93M | $-87M | $-110M | $-71M | |
| Net Income | $-88M | $-83M | $-105M | $-68M | |
| EPS (Basic) | $-1.63 | $-2.46 | $-36.94 | $-26.91 | |
| EPS (Diluted) | $-1.63 | $-2.46 | $-36.94 | $-26.91 | |
| Shares (Basic) | 54,143,162 | 33,700,550 | 2,848,529 | 2,770,352 | |
| Shares (Diluted) | 54,143,162 | 33,700,550 | 2,848,529 | 2,770,352 | |
| EBITDA | $-93M | $-87M | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $143M | $161M | · | · | |
| Short-term Investments | $389M | $351M | · | · | |
| Prepaid Expense | $15M | $17M | · | · | |
| Current Assets | $547M | $530M | · | · | |
| PP&E (Net) | $133M | $138M | · | · | |
| PP&E (Gross) | $186M | $186M | · | · | |
| Accum. Depreciation | $53M | $48M | · | · | |
| Other Non-current Assets | $539.0K | $556.0K | · | · | |
| Total Assets | $780M | $851M | · | · | |
| Accounts Payable | $7M | $6M | · | · | |
| Current Liabilities | $55M | $45M | · | · | |
| Capital Leases | $243M | $245M | · | · | |
| Other Non-current Liabilities | $15M | $10M | · | · | |
| Total Liabilities | $313M | $300M | · | · | |
| Common Stock | $5.0K | $5.0K | · | · | |
| Retained Earnings | $-1.09B | $-1.00B | · | · | |
| Stockholders' Equity | $466M | $551M | · | · | |
| Liabilities + Equity | $780M | $851M | · | · | |
| Shares Outstanding | 54,148,887 | 54,138,555 | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $7M | $3M | |
| Restructuring | $0 | · | · | · | |
| Operating Cash Flow | $-65M | $-90M | $-33M | $-55M | |
| CapEx | $251.0K | $262.0K | $22M | $22M | |
| Investing Cash Flow | $46M | $-203M | $-36M | $-214M | |
| Stock Issued | $25.0K | $277.0K | $529.0K | $21.0K | |
| Net Stock Activity | · | $277.0K | · | · | |
| Financing Cash Flow | $25.0K | $349M | $519.0K | $350M | |
| Free Cash Flow | · | $-90M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Operating Margin | -1854.2% | -1994.0% | · | · | |
| Net Margin | -1755.2% | -1894.0% | · | · | |
| EBITDA Margin | -1854.2% | -1994.0% | · | · | |
| ROA | -22.7% | -19.5% | · | · | |
| ROE | -37.9% | -30.1% | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 9.9 | 11.8 | · | · | |
| Quick Ratio | 9.6 | 11.4 | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Book Value / Share | $8.62 | $10.17 | · | · | |
| Revenue / Share | $0.09 | $0.13 | · | · | |
| Cash Flow / Share | · | $-2.66 | · | · | |
| Cash / Share | $2.63 | $2.98 | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Market Cap | $707M | $573M | · | · | |
| P/B | 1.5 | 1.0 | · | · | |
| P / Tangible Book | 1.5 | 1.0 | · | · | |
| P / Cash Flow | · | -6.4 | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 77 filers · $309.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 37 | 11 | 17 | 9 | · |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $65,170,473 | 4,993,906 | 21.07% | Shares |
| BlackRock, Inc. | $55,872,596 | 4,281,425 | 18.07% | Shares |
| Foresite Capital Management IV, LLC | $25,365,050 | 1,943,682 | 8.20% | Shares |
| Merck & Co., Inc. | $21,749,991 | 1,666,666 | 7.03% | Shares |
| Foresite Capital Management V, LLC | $17,212,728 | 1,318,983 | 5.57% | Shares |
| Capital World Investors | $15,346,069 | 1,175,944 | 4.96% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $12,041,326 | 922,707 | 3.89% | Shares |
| EcoR1 Capital, LLC | $9,560,508 | 732,606 | 3.09% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $7,270,592 | 556,955 | 2.35% | Shares |
| BAKER BROS. ADVISORS LP | $7,249,993 | 555,555 | 2.34% | Shares |
| ALLIANCEBERNSTEIN L.P. | $6,791,175 | 641,888 | 2.20% | Shares |
| SOROS CAPITAL MANAGEMENT LLC | $6,324,969 | 484,672 | 2.05% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $4,946,263 | 379,024 | 1.60% | Shares |
| STATE STREET CORP | $4,620,914 | 354,093 | 1.49% | Shares |
| FRANKLIN RESOURCES INC | $4,567,500 | 350,000 | 1.48% | Shares |
| StepStone Group LP | $4,182,697 | 395,340 | 1.35% | Shares |
| General Catalyst Group Management, LLC | $3,983,291 | 305,233 | 1.29% | Shares |
| UBS Group AG | $3,444,313 | 263,932 | 1.11% | Shares |
| Parkman Healthcare Partners LLC | $3,341,492 | 256,053 | 1.08% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2,376,470 | 182,105 | 0.77% | Shares |
| Schonfeld Strategic Advisors LLC | $2,346,063 | 179,775 | 0.76% | Shares |
| NORTHERN TRUST CORP | $2,295,847 | 175,927 | 0.74% | Shares |
| Ensign Peak Advisors, Inc | $2,224,895 | 170,490 | 0.72% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,943,080 | 148,895 | 0.63% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,936,751 | 148,410 | 0.63% | Shares |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $1,755,199 | 134,498 | 0.57% | Shares |
| MILLENNIUM MANAGEMENT LLC | $1,735,911 | 133,020 | 0.56% | Shares |
| Comprehensive Financial Management LLC | $1,517,402 | 116,276 | 0.49% | Shares |
| Burkehill Global Management, LP | $1,500,750 | 115,000 | 0.49% | Shares |
| Affinity Asset Advisors, LLC | $1,278,913 | 98,001 | 0.41% | Shares |
| TD Asset Management Inc | $744,816 | 57,074 | 0.24% | Shares |
| ALPS ADVISORS INC | $717,071 | 54,948 | 0.23% | Shares |
| Invesco Ltd. | $664,245 | 50,900 | 0.21% | Shares |
| Bank of New York Mellon Corp | $623,634 | 47,788 | 0.20% | Shares |
| TCG Crossover Management, LLC | $494,621 | 37,902 | 0.16% | Shares |
| BANK OF AMERICA CORP /DE/ | $490,354 | 37,575 | 0.16% | Shares |
| POLEN CAPITAL MANAGEMENT LLC | $466,433 | 35,742 | 0.15% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $461,409 | 35,357 | 0.15% | Shares |
| ProShare Advisors LLC | $387,389 | 29,685 | 0.13% | Shares |
| Nuveen, LLC | $378,293 | 28,988 | 0.12% | Shares |
| XTX Topco Ltd | $358,288 | 27,455 | 0.12% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $349,701 | 26,797 | 0.11% | Shares |
| RHUMBLINE ADVISERS | $319,496 | 24,483 | 0.10% | Shares |
| DEUTSCHE BANK AG\ | $280,862 | 21,522 | 0.09% | Shares |
| WELLS FARGO & COMPANY/MN | $252,491 | 19,348 | 0.08% | Shares |
| Jump Financial, LLC | $235,800 | 18,069 | 0.08% | Shares |
| CITIGROUP INC | $218,966 | 16,779 | 0.07% | Shares |
| TUDOR INVESTMENT CORP ET AL | $195,750 | 15,000 | 0.06% | Shares |
| MetLife Investment Management, LLC | $179,503 | 13,755 | 0.06% | Shares |
| CITADEL ADVISORS LLC | $169,950 | 13,023 | 0.05% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| The Column Group IV GP, LP, The Column Group IV, LP, The Column Group IV-A, LP, The Column Group Opportunity III, LP, The Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Tim Kutzkey, Peter Svennilson | Feb. 12, 2026 | 11.60% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 8 insiders · 5 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Roger M Perlmutter | Chief Executive Officer and Director | March 2, 2026 A | 284,857 | 0 | 0 | $0 |
| Alfred Lloyd Bowie Jr. | Chief Financial Officer | March 2, 2026 A | · | 0 | 0 | $0 |
| Michael A Klobuchar | Chief Operating Officer | March 2, 2026 A | · | 0 | 0 | $0 |
| Benjamin Bruno Thorner | General Counsel and Chief Business Officer | March 2, 2026 A | · | 0 | 0 | $0 |
| Roy D. Baynes | Chief Medical Officer | March 2, 2026 A | · | 0 | 0 | $0 |
| Robert Luther Huffines | Director | March 2, 2026 A | · | 0 | 0 | $0 |
| Kenneth C Frazier | Director | March 2, 2026 A | 111,111 | 1 | 0 | $1,999,998 |
| Josh Wolfe | Director | Feb. 6, 2026 C | 2,294,653 | 2 | 0 | $4,999,968 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 12 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.11% | 39,010 SH | Oct. 2, 2026 | Daily |
| IWC · iShares Trust | 0.05% | 74,035 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 124,951 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 5,894 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 16,148 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 140,757 SH | Sept. 11, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 548,830 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 10,357 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 241,101 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 660,117 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,902 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 63,574 SH | Sept. 11, 2026 | Daily |
EIKN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
5 analysts · 2026-09-28Mean target $24.60 +235.6%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| EIKN | · | · | · | · | · | · |
| KYTX | $568M | -2.6 | · | · | -77.4% | · |
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | · |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | · |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | · |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.